Meyka AI API is live for developers.Start building.
Advertisement
OpGen, Inc.

OpGen, Inc. (OPGN) Stock Overview

Explore OpGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

OPGNNASDAQ
HealthcareMedical - Diagnostics & Research
$23.91
$0.00(0.00%)
U.S. Market opens in 56h 0m
Advertisement

OpGen, Inc. (OPGN)

Meyka AI Score

Z

Key Financials

Market Cap242.7M
P/E Ratio10.20
EPS (TTM)$0.18
ROE1.58%
Fundamental Analysis

AI Price Forecasts

1 Month$22.75
3 Months$40.76
1 Year Target$2.60

OPGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OpGen, Inc. (OPGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.20 and a market capitalization of 242.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.96%
5-Day Change
1.74%
1-Month Change
N/A
3-Month Change
32.17%
6-Month Change
23909900.72%
Year-to-Date (YTD) Change
50.38%
1-Year Change
476.14%
3-Year Change
127.71%
5-Year Change
-94.98%
All-Time (Max) Change
-100.00%

Contact Information

240 813 1260
9717 Key West Avenue, Rockville, MD, 20850

Company Facts

850 Employees
IPO DateMay 5, 2015
CountryUS

Frequently Asked Questions